Global Blood Therapeutics, Inc. (GBT) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Global Blood Therapeutics, Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
-6.07
Burn Risk
P/B Ratio
9.38
Weak
WeakModerateStrong
Earnings Yield
-16.46%
Yield Gap
Profitability Health
TTMReturn on Equity
-154.32%
Weak
WeakModerateStrong
Operating Margin
-147.44%
Weak
WeakModerateStrong
Net Profit Margin
-155.63%
Weak
WeakModerateStrong
Efficiency & Liquidity
TTMCurrent Ratio
9.11
Strong
WeakModerateStrong
Quick Ratio
8.45
Strong
WeakModerateStrong
Asset Turnover
0.21x
Weak
WeakModerateStrong
Inventory Turnover
0.06x
Weak
WeakModerateStrong
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
-14.12%
Weak
WeakModerateStrong
EV / Free Cash Flow
-6.99x
Strong
WeakModerateStrong
Net Debt / EBITDA
0.09x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
1.054
Strong
WeakModerateStrong
Return on Invested Capital
-33.51%
Weak
WeakModerateStrong
Cash Conversion Cycle
4798.65 days
Weak
WeakModerateStrong
Fortress screener guardrails
1/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for GBT.
View Financial Statements